Predictors Related to the Non-alcoholic Fatty Liver Disease

Ha-Young NA; Deok-Ju BAEK; Sang-Hyun LEE; Young-Eun CHOI; Kyung-Hee CHO; Sung-Bae PARK; Young-Sung KIM; Seung-Soo KIM.
Korean Journal of Family Medicine ; : 94-100, 2010.
Artículo en Ko | WPRIM | ID: wpr-37301

Documentos relacionados

  1. Chromosome-level genome assembly of the Muscovy duck provides insight into fatty liver susceptibility.
  2. Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies.
  3. Hope on the Horizon: Promising Therapies for Steatotic Liver Disease.
  4. Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance.
  5. Transcription profiling of cadmium-exposed livers reveals alteration of lipid metabolism and predisposition to hepatic steatosis.
  6. Non-alcoholic fatty liver disease.
  7. Pediatricians' practices and knowledge of metabolic dysfunction-associated steatotic liver disease: An international survey.
  8. Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD.
  9. [Metabolic steatotic liver disease: the move towards an inclusive definition].
  10. Mechanisms of Lipid Droplet Accumulation in Steatotic Liver Diseases.